# OnCo record rejuv-second-screening-after-treatment-compared (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/rejuv-second-screening-after-treatment-compared/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "rejuv-second-screening-after-treatment-compared" ;
  schema:name "Screening survivors: where the UK, American and European answers differ"@en ;
  schema:alternateName "Survivorship screening guidelines"@en, "Late effects surveillance"@en, "BETER consortium"@en, "Risk-based survivorship care"@en ;
  schema:description "Three systems have built screening for survivors and they do not agree. England runs an organised programme with fixed ages and automatic referral; the United States issues a guideline and leaves the arranging to the patient; the Netherlands runs a national survivorship clinic network. They differ on when to start and whom to include."@en ;
  schema:url <https://onco.cc/terms/rejuv-second-screening-after-treatment-compared/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cancer_screening> ;
  schema:citation <https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html>, <https://doi.org/10.3322/canjclin.57.2.75>, <https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols/tests-and-frequency-of-testing-for-women-at-very-high-risk--2>, <https://doi.org/10.1002/cam4.71113>, <https://doi.org/10.1016/j.ctrv.2017.11.005>, <https://childrensoncologygroup.org/survivorship> ;
  onco:tag "rejuvenation", "survivorship", "second-cancers", "screening", "survivorship" ;
  onco:related <https://onco.cc/terms/rejuv-second-uk-very-high-risk-breast-screening/>, <https://onco.cc/terms/second-primary-breast-after-chest-radiotherapy/>, <https://onco.cc/terms/second-primary-thyroid-after-neck-radiotherapy/>, <https://onco.cc/terms/second-primary-bowel-after-abdominal-radiotherapy/>, <https://onco.cc/terms/second-primary-lung-after-chest-radiotherapy/>, <https://onco.cc/terms/rejuv-second-cancers-overview/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/lung-cancer/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/prevention/> ;
  onco:technologies <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/mri/>, <https://onco.cc/technologies/mammography/>, <https://onco.cc/terms/colonoscopy/>, <https://onco.cc/technologies/low-dose-ct-screening/> ;
  onco:terms <https://onco.cc/terms/lymphoma-living-hodgkin-survivorship-screening/>, <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/late-effects/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-early-detection/>, <https://onco.cc/bottlenecks/b-survivorship/>, <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-regulatory-fragmentation/> .